Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Long-term efficacy of B cell depletion therapy on lung and skin involvement in diffuse systemic sclerosis.
Incidental MRI anomalies suggestive of multiple sclerosis: the radiologically isolated syndrome.
A Study to Evaluate the Long-term Safety, Tolerability and Effect of Daily Oral Laquinimod 0.6 mg on Disease Course in Subjects With Relapsing Multiple Sclerosis
Interferon-β and serum 25-hydroxyvitamin D interact to modulate relapse risk in MS.
Don't stress about it!: Is stress management a disease-modifying therapy for multiple sclerosis?
TNF receptor 1 genetic risk mirrors outcome of anti-TNF therapy in multiple sclerosis.
Transverse myelitis associated with heroin and cannabis abuse: a new issue from the past.
The AusD Study: A Population-based Study of the Determinants of Serum 25-Hydroxyvitamin D Concentration Across a Broad Latitude Range.
In vivo evidence of glutamate toxicity in multiple sclerosis.
Evaluation of Dalfampridine Extended Release 5 and 10 mg in Multiple Sclerosis: A Randomized Controlled Trial.
Th17 central memory T cells are reduced by FTY720 in patients with multiple sclerosis.
Correlates of Executive Functions in Multiple Sclerosis Based on Structural and Functional MR Imaging: Insights from a Multicenter Study.
Dried Blood Spot Methodology in Combination With Liquid Chromatography/Tandem Mass Spectrometry Facilitates the Monitoring of Teriflunomide.
Olive oil phenols and neuroprotection.
Delta 9-tetrahydrocannabinol: a novel treatment for experimental autoimmune encephalomyelitis.
Biologics at Novartis
Teva and Takeda announce agreement for glatiramer acetate for multiple sclerosis treatment in Japan
Modest familial risks for multiple sclerosis: a registry-based study of the population of Sweden.
From "Wheelchair Circuit" to "Wheelchair Assessment Instrument for People with Multiple Sclerosis": Reliability and Validity Analysis of a Test to Assess Driving Skills in Manual Wheelchair Users With Multiple Sclerosis.
Mesenchymal stem cells expressing vasoactive intestinal peptide ameliorate symptoms in a model of chronic multiple sclerosis.
High risk of MS in Iranian immigrants in Gothenburg, Sweden.
On dihydroorotate dehydrogenases, their inhibitors and uses.
Birth outcomes of pregnancies fathered by men with multiple sclerosis.
The contemporary spectrum of multiple sclerosis misdiagnosis: A multicenter study.
Multiple sclerosis: Spinal cord grey matter loss correlates with disability in MS.
Pages
« first
‹ previous
…
117
118
119
120
121
122
123
124
125
…
next ›
last »